Back to results
Not yet recruitingPhase 1

Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease

NCT05094011

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Contact

Kuo-Wei Hsueh, Ph. D.

886-03-5820208fskenneth@taimito.com
View on ClinicalTrials.gov
Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease — TrialFind